A pioneer in targeted nano-liposomes based drug delivery across the Blood-Brain-Barrier
Nextage Therapeutics (TASE: NXTG) is a pioneer in targeted nano-liposomes based drug delivery across the blood-brain-barrier. The company has developed a proprietary BTLs drug delivery platform which is being studied for various therapeutic applications, and its lead drug candidate is currently under development for treatment of glioblastoma. Through its su…